Login
$SNY
$48.05 -$0.34 (0.7%) After hours

Company Executives

Officer Age In this role Source
François Roger
Executive Vice President, Chief Financial Officer
Not stated Since 2024
2 years
Natalie Bickford
Executive Vice President, Chief People Officer
Not stated Not stated
Emmanuel Frenehard
Executive Vice President, Chief Digital Officer
Not stated Not stated
Roy Papatheodorou
Executive Vice President, General Counsel
Not stated Not stated
Houman Ashrafian
Executive Vice President, Head of Research and Development
Not stated Not stated
Audrey Duval
Executive Vice President, Corporate Affairs
Not stated Not stated
Brian Foard
Executive Vice President, Specialty Care (until end-of-day on February 28, 2026)
Not stated Not stated
Brendan O’Callaghan
Executive Vice President, Global Manufacturing & Supply
Not stated Not stated
Madeleine Roach
Executive Vice President, Business Operations
Not stated Not stated
Thomas Triomphe
Executive Vice President, Vaccines
Not stated Since 2020
6 years
Paul Hudson
58 Not stated
Olivier Charmeil
Not stated Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
14
serving now
Independent
1 of 1
stated in the proxy; 13 not stated
Average tenure
4.2 years
from year joined
CEO also chairs the board
No
Frédéric Oudéa
Director Age On board Independent Committees Source
Frédéric Oudéa
62 2023
3 years
Not stated
Appointments, Governance & CSR Committee
Christophe Babule
60 2019
7 years
Independent
Audit Committee
Clotilde Delbos
58 2024
2 years
Not stated
Audit Committee Compensation Committee · Chair
Rachel Duan
55 2020
6 years
Not stated None stated
Carole Ferrand
55 2022
4 years
Not stated
Audit Committee · Chair
Lise Kingo
64 2020
6 years
Not stated None stated
Jean-Paul Kress
60 2025
1 year
Not stated None stated
Patrick Kron
72 2014
12 years
Not stated
Appointments, Governance & CSR Committee · Chair Compensation Committee
Anne-Françoise Nesmes
54 2024
2 years
Not stated
Audit Committee
John Sundy
64 2024
2 years
Not stated None stated
Emile Voest
66 2022
4 years
Not stated None stated
Antoine Yver
68 2022
4 years
Not stated None stated
Wolfgang Laux
58 2021
5 years
Not stated None stated
Humberto De Sousa
48 2025
1 year
Not stated None stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Sanofi has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support